Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Johnson & Johnson Dips On Q4 Earnings
Johnson & Johnson Dips On Q4 Earnings: Here's What The Market Isn't Seeing
Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ stock is a Buy.
Johnson & Johnson Tops Q4 EPS Forecasts
Overall,
Johnson & Johnson
had a strong quarter, continuing to expand its product pipeline and positioning itself well amid market fluctuations.
Johnson & Johnson
is a diversified healthcare giant ...
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
Johnson & Johnson
(JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...
Bears hire Ben Johnson
10 things we heard at Ben Johnson’s Chicago Bears introduction, including why he’s prepared to be a head coach
New Chicago Bears coach Ben Johnson wrapped up the opening statement of his introductory news conference Wednesday at Halas Hall with a declaration. “Our mission, starting this spring, is to win and to win now,
Bears' Ben Johnson continues adding to his staff, poaching coaches from the Lions and Cowboys, per reports
Ben Johnson is quickly building his first coaching staff as the Bears head coach, and he's poaching from a few other teams in the process. The Bears are working to finalize a deal with Lions receivers coach Antwaan Randle El to be their new assistant head coach/wide receivers coach,
Bears hire Ben Johnson: Coaching staff rumors tracker
The Chicago Bears have hired Ben Johnson as their new head coach, and now the attention has turned to Johnson building his coaching staff. Johnson preached the importance of surrounding himself with experienced coaches that he can lean on,
Johnson invites Trump to address Congress
Trump to address joint session of Congress on March 4
U.S. President Donald Trump has been invited to address a joint session of Congress on March 4, Republican House of Representatives Speaker Mike Johnson said on Saturday. "It is my distinct honor and great privilege to invite President Donald Trump to address a Joint Session of Congress on Tuesday,
Johnson invites Trump to address Congress on March 4
Speaker Mike Johnson on Saturday extended an invitation for President Donald Trump to address a joint session of Congress on March 4, the first in Trump’s second presidency. In a letter to the president,
Speaker Mike Johnson invites Trump to deliver address to Congress
House Speaker Mike Johnson invited President Donald Trump to deliver an address to Congress in March, a speech that would mark Trump's first joint address to Congress of his second term.
2d
“Johnson & Johnson: Buy Rating Reaffirmed Despite Price Target Cut, Growth Prospects Highlighted”
Leerink Partners analyst Marc Goodman maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...
2d
Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst
Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
2d
on MSN
Johnson & Johnson's SWOT analysis: oncology portfolio drives growth amid challenges
Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...
2d
Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
15h
on MSN
Is Johnson & Johnson (JNJ) Among The Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years?
We recently published a list of 15 Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years. In this article, we are going ...
2d
on MSN
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
Supply Chain
2d
Podcast | How Healthcare Giant Johnson & Johnson Is Making Its Supply Chain Sustainable
How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its ...
MassDevice
3d
Johnson & Johnson MedTech sales grow 6.2% in 2024, driven by EP, Abiomed
Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Chicago Bears
Detroit Lions
Q4 2024
New York
Brooklyn Nets
Feedback